Hepatocellular carcinoma (HCC): the most promising therapeutic targets in the preclinical arena based on tumor biology characteristics-Reference-Cited by-同舟云学术

Hepatocellular carcinoma (HCC): the most promising therapeutic targets in the preclinical arena based on tumor biology characteristics

Published:2021-08-03 Issue:8 Volume:25 Page:645-658
ISSN:1472-8222
Container-title:Expert Opinion on Therapeutic Targets
language:en
Short-container-title:Expert Opinion on Therapeutic Targets

Author:

Wang Haichuan¹²^ORCID,Chen Xin²^ORCID,Calvisi Diego F.³^ORCID

Affiliation:

1. Liver Transplantation Division, Department of Liver Surgery and Laboratory of Liver Surgery, West China Hospital, Sichuan University, Chengdu, Sichuan, China

2. Department of Bioengineering and Therapeutic Sciences and Liver Center, University of California, San Francisco, California, USA

3. Institute of Pathology, University of Regensburg, Regensburg, Germany

Funder

NIH

Post-Doctor Research Project, West China Hospital, Sichuan University

Publisher

Informa UK Limited

Subject

Clinical Biochemistry,Drug Discovery,Pharmacology,Molecular Medicine

Link

https://www.tandfonline.com/doi/pdf/10.1080/14728222.2021.1976142

Reference128 articles.

1. Hepatocellular Carcinoma

2. Risk Factors, Pathogenesis, and Strategies for Hepatocellular Carcinoma Prevention: Emphasis on Secondary Prevention and Its Translational Challenges

3. Trans-ancestry mutational landscape of hepatocellular carcinoma genomes

4. Comprehensive and Integrative Genomic Characterization of Hepatocellular Carcinoma

5. Efficacy and Safety of Nivolumab Plus Ipilimumab in Patients With Advanced Hepatocellular Carcinoma Previously Treated With Sorafenib

Cited by 7 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Subcellular distribution and Nrf2/Keap1-interacting properties of Glutathione S-transferase P in hepatocellular carcinoma;Archives of Biochemistry and Biophysics;2024-07

2. Survival strategies: How tumor hypoxia microenvironment orchestrates angiogenesis;Biomedicine & Pharmacotherapy;2024-07

3. Exploiting the immune system in hepatic tumor targeting: Unleashing the potential of drugs, natural products, and nanoparticles;Pathology - Research and Practice;2024-04

4. Machine learning-based disulfidptosis-related lncRNA signature predicts prognosis, immune infiltration and drug sensitivity in hepatocellular carcinoma;Scientific Reports;2024-02-22

5. Machine Learning-Based Disulfidptosis-Related lncRNA Signature Predicts Prognosis, Immune Infiltration and Drug Sensitivity in Hepatocellular Carcinoma;2023-09-11